These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 34960208)
1. Public Perceptions and Acceptance of COVID-19 Booster Vaccination in China: A Cross-Sectional Study. Lai X; Zhu H; Wang J; Huang Y; Jing R; Lyu Y; Zhang H; Feng H; Guo J; Fang H Vaccines (Basel); 2021 Dec; 9(12):. PubMed ID: 34960208 [TBL] [Abstract][Full Text] [Related]
2. Acceptance of the COVID-19 vaccine booster dose and associated factors among the elderly in China based on the health belief model (HBM): A national cross-sectional study. Qin C; Yan W; Du M; Liu Q; Tao L; Liu M; Liu J Front Public Health; 2022; 10():986916. PubMed ID: 36589991 [TBL] [Abstract][Full Text] [Related]
3. Acceptance of COVID-19 boosters among hypertensive patients in China: A multicenter cross-sectional study. Yan Y; Chen Q; Nuermaimaiti A; Xiao Y; Chang L; Ji H; Sun H; Song Q; Gao Y; Xu J; Wang L Hum Vaccin Immunother; 2023 Dec; 19(3):2283315. PubMed ID: 37982140 [TBL] [Abstract][Full Text] [Related]
4. Acceptance of COVID-19 vaccine booster doses among the Adult Population in Ghana: a cross-sectional study using the Health Belief Model. Eshun G; Kyei-Arthur F; Abdou MS; Agyekum MW; Sarfo M; Agbenyeavu JK; Addai SA; Adjei JA; Obeng N; Turzin JK; Ghazy RM BMC Public Health; 2024 Sep; 24(1):2673. PubMed ID: 39350125 [TBL] [Abstract][Full Text] [Related]
5. Association Between Risk Perception and Acceptance for a Booster Dose of COVID-19 Vaccine to Children Among Child Caregivers in China. Qin C; Wang R; Tao L; Liu M; Liu J Front Public Health; 2022; 10():834572. PubMed ID: 35372197 [TBL] [Abstract][Full Text] [Related]
6. Multi-dimensional potential factors influencing COVID-19 vaccine booster acceptance and hesitancy among university academic community in Bangladesh: A cross-sectional comparative study. Roy DN; Azam MS; Islam E PLoS One; 2023; 18(4):e0281395. PubMed ID: 37053270 [TBL] [Abstract][Full Text] [Related]
7. Acceptance of COVID-19 Vaccine Booster Doses Using the Health Belief Model: A Cross-Sectional Study in Low-Middle- and High-Income Countries of the East Mediterranean Region. Ghazy RM; Abdou MS; Awaidy S; Sallam M; Elbarazi I; Youssef N; Fiidow OA; Mehdad S; Hussein MF; Adam MF; Abdullah FSA; Rebai WK; Raad EB; Hussein M; Shehata SF; Ismail II; Salam AA; Samhouri D Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231447 [TBL] [Abstract][Full Text] [Related]
8. Factors related to first COVID-19 booster vaccine acceptance in Indonesia: A cross-sectional multi-center study. Mohi AR; Kusuma IY; Massi MN; Bahar MA Narra J; 2024 Aug; 4(2):e858. PubMed ID: 39280294 [TBL] [Abstract][Full Text] [Related]
9. Exploring the Willingness of the COVID-19 Vaccine Booster Shots in China Using the Health Belief Model: Web-Based Online Cross-Sectional Study. Hu D; Liu Z; Gong L; Kong Y; Liu H; Wei C; Wu X; Zhu Q; Guo Y Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016224 [TBL] [Abstract][Full Text] [Related]
10. Willingness to pay for and willingness to vaccinate with the COVID-19 vaccine booster dose in China. Zhou HJ; Pan L; Shi H; Luo JW; Wang P; Porter HK; Bi Y; Li M Front Pharmacol; 2022; 13():1013485. PubMed ID: 36204240 [No Abstract] [Full Text] [Related]
11. Preference and Willingness to Pay for the Regular COVID-19 Booster Shot in the Vietnamese Population: Theory-Driven Discrete Choice Experiment. Tran BX; Do AL; Boyer L; Auquier P; Le HT; Le Vu MN; Dang THT; Cao KM; Le LDT; Cu LTN; Ly BV; Nguyen DAT; Nguyen MD; Latkin CA; Ho RCM; Ho CSH; Zhang MWB JMIR Public Health Surveill; 2023 Jan; 9():e43055. PubMed ID: 36599156 [TBL] [Abstract][Full Text] [Related]
12. Multi-dimensional psychosocial factors influencing the willingness to receive a COVID-19 vaccine booster: A survey among the public in Mainland China. Lin Y; Huang Z; Xu X; Du W; Alias H; Hu Z; Wong LP Hum Vaccin Immunother; 2022 Nov; 18(6):2126667. PubMed ID: 36165498 [TBL] [Abstract][Full Text] [Related]
13. Acceptability of COVID-19 booster vaccine in malaysia: a cross-sectional study. Khoo CMJ; Dea EZQ; Law LY; Wong SST; Ng KY; Bakhtiar A Sci Rep; 2024 Apr; 14(1):8421. PubMed ID: 38600166 [TBL] [Abstract][Full Text] [Related]
14. The acceptance to heterologous booster vaccination of COVID-19 vaccine among HCWs and targeted population: A cross-sectional study in central China. Qin W; Zhang X; Wang Y; Pan F; Cheng K; Huang F; Song J; Su H Front Public Health; 2022; 10():943876. PubMed ID: 35979461 [TBL] [Abstract][Full Text] [Related]
15. Dynamic Trends and Underlying Factors of COVID-19 Vaccine Booster Hesitancy in Adults: Cross-Sectional Observational Study. Wu J; Ma M; Li Q; Guo X; Tarimo CS; Jia S; Zhou X; Wang M; Gu J; Miao Y; Ye B JMIR Public Health Surveill; 2023 Aug; 9():e44822. PubMed ID: 37526963 [TBL] [Abstract][Full Text] [Related]
16. COVID-19 Vaccine Booster Hesitancy (VBH) and Its Drivers in Algeria: National Cross-Sectional Survey-Based Study. Lounis M; Bencherit D; Rais MA; Riad A Vaccines (Basel); 2022 Apr; 10(4):. PubMed ID: 35455371 [TBL] [Abstract][Full Text] [Related]
17. Willingness of people living with HIV to receive a second COVID-19 booster dose: a multicenter cross-sectional study in China. Lan X; Su B; Liang S; Yu M; Qiao Y; Wang L; Song M; Wang Y; Xu J Front Public Health; 2023; 11():1227277. PubMed ID: 37680268 [TBL] [Abstract][Full Text] [Related]
18. Acceptance of Annual Booster Doses of COVID-19 Vaccines Among Indian Healthcare Professionals: A Pan-India Cross-Sectional Survey. Krishna E; Karthikeyan V; Ahmad S; Ranjan A; Hasan Km A; Pandey S; Kumar P; Singh CM Cureus; 2023 Nov; 15(11):e49363. PubMed ID: 38146559 [TBL] [Abstract][Full Text] [Related]
19. Acceptance of a Third Dose of COVID-19 Vaccine and Associated Factors in China Based on Health Belief Model: A National Cross-Sectional Study. Qin C; Wang R; Tao L; Liu M; Liu J Vaccines (Basel); 2022 Jan; 10(1):. PubMed ID: 35062750 [TBL] [Abstract][Full Text] [Related]
20. Health Belief Model and parents' acceptance of the Pfizer-BioNTech and Sinopharm COVID-19 vaccine for children aged 5-18 years Old: A national survey. Vatcharavongvan P; Boonyanitchayakul N; Khampachuea P; Sinturong I; Prasert V Vaccine; 2023 Feb; 41(8):1480-1489. PubMed ID: 36707336 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]